Literature DB >> 3586151

A population-based study of prostatectomy: outcomes associated with differing surgical approaches.

N P Roos, E W Ramsey.   

Abstract

Data from the universal health insurance system in Manitoba, Canada were used to describe the short-term (2 years) and long-term (8 years) outcomes associated with prostatectomy for nonmalignant conditions (all 2,699 procedures were performed from 1974 to 1976). In a system with high quality urological care (more than 90 per cent of the procedures were performed by urologists) no superior operative results for transurethral procedures were found. Postoperative mortality rates following transurethral prostatectomy were similar to or higher than rates for open procedures, and the rate of repeat prostatectomy, was considerably higher following transurethral resection. Dilation for urethral stricture was most common after suprapubic prostatectomy and least common after retropubic prostatectomy. Patients were followed for 8 years and those who underwent transurethral prostatectomy required an additional prostatic operation at a constant rate (2 per cent per year). By the end of the followup period 16.8 per cent of the transurethral prostatectomy patients had undergone a second prostatectomy compared to 7 per cent or less of those who initially underwent an open procedure.

Entities:  

Mesh:

Year:  1987        PMID: 3586151     DOI: 10.1016/s0022-5347(17)44442-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Review of current and future approaches to the management of benign prostatic hyperplasia.

Authors:  J C Gingell
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401

Review 2.  Benign prostatic hyperplasia and its treatment.

Authors:  J B Stimson; S D Fihn
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

3.  Irreversible renal failure in men with outflow obstruction: is it a preventable disease?

Authors:  D E Neal
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 4.  Comparison of the cost-effectiveness of various therapies for common prostatic disorders.

Authors:  E A Amin; M Amin
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 5.  Treatment options for benign prostatic hyperplasia.

Authors:  A J Portis; D R Mador
Journal:  Can Fam Physician       Date:  1997-08       Impact factor: 3.275

6.  Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group.

Authors:  G D Chisholm; S J Carne; J M Fitzpatrick; N J George; J C Gingell; J W Keen; R S Kirby; D Kirk; E P O'Donoghue; W B Peeling
Journal:  Postgrad Med J       Date:  1995-03       Impact factor: 2.401

7.  Evaluation and results of treatments for prostatism.

Authors:  D E Neal
Journal:  Urol Res       Date:  1994

8.  Monitoring adverse outcomes of surgery using administrative data.

Authors:  L L Roos; N P Roos; S M Sharp
Journal:  Health Care Financ Rev       Date:  1987-12

9.  Potential for inpatient-outpatient substitution with diagnosis-related groups.

Authors:  N P Roos; J L Freeman
Journal:  Health Care Financ Rev       Date:  1989

10.  Cystostomy-free open suprapubic transvesical prostatectomy: Is it a safe method?

Authors:  Abbas Hassanpour; Mohammad Mehid Hosseini; Alireza Yousefi; Reza Inaloo
Journal:  Urol Ann       Date:  2016 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.